Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability

被引:644
作者
Eliceiri, BP
Paul, R
Schwartzberg, PL
Hood, JD
Leng, J
Cheresh, DA
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Vasc Biol, La Jolla, CA 92037 USA
[3] Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1016/S1097-2765(00)80221-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Src kinase activity was found to protect endothelial cells from apoptosis during vascular endothelial growth factor (VEGF)-, but not basic fibroblast growth factor (bFGF)-, mediated angiogenesis in chick embryos and mice. In fact, retroviral targeting of kinase-deleted Src to tumor-associated blood vessels suppressed angiogenesis and the growth of a VEGF-producing tumor. Although mice lacking individual Src family kinases (SFKs) showed normal angiogenesis, mice deficient in pp60(c-src) or pp62(c-yes) showed no VEGF-induced vascular permeability (VP), yet fyn(-/-) mice displayed normal VP. In contrast, inflammation-mediated VP appeared normal in Src-deficient mice. Therefore, VEGF-, but not bFGF-, mediated angiogenesis requires SFK activity in general, whereas the VP activity of VEGF specifically depends on the SFKs, Src, or Yes.
引用
收藏
页码:915 / 924
页数:10
相关论文
共 41 条
[1]   AN EFFICIENT AND FLEXIBLE SYSTEM FOR CONSTRUCTION OF ADENOVIRUS VECTORS WITH INSERTIONS OR DELETIONS IN EARLY REGION-1 AND REGION-3 [J].
BETT, AJ ;
HADDARA, W ;
PREVEC, L ;
GRAHAM, FL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) :8802-8806
[2]   REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS [J].
BROOKS, PC ;
CLARK, RAF ;
CHERESH, DA .
SCIENCE, 1994, 264 (5158) :569-571
[3]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[4]   Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling [J].
Broome, MA ;
Hunter, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16798-16806
[5]   SRC-RELATED PROTEIN-TYROSINE KINASES ARE PHYSICALLY ASSOCIATED WITH THE SURFACE-ANTIGEN CD36 IN HUMAN DERMAL MICROVASCULAR ENDOTHELIAL-CELLS [J].
BULL, HA ;
BRICKELL, PM ;
DOWD, PM .
FEBS LETTERS, 1994, 351 (01) :41-44
[6]   ADENOVIRUS-MEDIATED OVER-EXPRESSION OF THE CYCLIN CYCLIN-DEPENDENT KINASE INHIBITOR, P21 INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION IN THE RAT CAROTID-ARTERY MODEL OF BALLOON ANGIOPLASTY [J].
CHANG, MW ;
BARR, E ;
LU, MM ;
BARTON, K ;
LEIDEN, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2260-2268
[7]   INHIBITION OF CAPILLARY MORPHOGENESIS AND ASSOCIATED APOPTOSIS BY DOMINANT-NEGATIVE MUTANT TRANSFORMING GROWTH-FACTOR-BETA RECEPTORS [J].
CHOI, ME ;
BALLERMANN, BJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (36) :21144-21150
[8]   TUMOR VASCULAR-PERMEABILITY FACTOR STIMULATES ENDOTHELIAL-CELL GROWTH AND ANGIOGENESIS [J].
CONNOLLY, DT ;
HEUVELMAN, DM ;
NELSON, R ;
OLANDER, JV ;
EPPLEY, BL ;
DELFINO, JJ ;
SIEGEL, NR ;
LEIMGRUBER, RM ;
FEDER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1470-1478
[9]  
COURTNEIDGE SA, 1993, DEVELOPMENT, P57
[10]  
DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974